4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one(HMDO-CL)
Intermediates of Azilsartan medoxomil (91526-18-0)
4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one (HMDO-CL) is a key intermediate used in the production of various
pharmaceuticals and agrochemicals. Its hydroxymethyl group enhances its reactivity, making it suitable for creating
complex chemical structures. HMDO-CL's role in organic synthesis, particularly in forming heterocyclic compounds,
underscores its importance in medicinal chemistry. It enables the development of innovative drugs and advanced
materials, contributing to progress in chemical research and industrial applications.